Why would a provider deny Wegovy?

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve probably wondered: Can I actually get these prescribed through telehealth? The short answer is yes—and for most Americans, it’s surprisingly straightforward.

As of December 2025, telehealth has become a legitimate, legal pathway to access GLP-1 weight loss medications across the United States. Because these medications aren’t controlled substances, federal law doesn’t require an in-person visit before prescribing them. However, the specifics vary by state, and understanding these nuances can help you navigate the process with confidence.

Understanding GLP-1 Medications and Telehealth

What Are GLP-1 Weight Loss Medications?

GLP-1 (glucagon-like peptide-1) agonists are injectable medications that help with weight management by regulating appetite and blood sugar. The three most common options include:

• Wegovy (semaglutide 2.4mg) – FDA-approved specifically for chronic weight management
• Ozempic (semaglutide 0.5-1mg) – FDA-approved for Type 2 diabetes but often used off-label for weight loss
• Mounjaro (tirzepatide) – FDA-approved for Type 2 diabetes; its obesity-specific version, Zepbound, launched in late 2023

These medications work differently than older ‘diet pills.’ They’re not stimulants or controlled substances—they’re hormone-based treatments that help your body regulate hunger signals more effectively.

Why Telehealth Works for Weight Loss Treatment

Telehealth has proven especially valuable for obesity care. Regular in-person appointments can be a significant barrier for many people—whether due to scheduling conflicts, transportation challenges, or limited access to specialists in rural areas. Virtual consultations allow licensed healthcare providers to:

• Conduct comprehensive medical evaluations via video
• Review your health history and current medications
• Calculate your BMI and assess eligibility
• Create personalized treatment plans
• Monitor your progress through regular follow-ups
• Send prescriptions electronically to your pharmacy

The key is that telehealth providers must meet the same standards of care as in-person clinics. That means thorough evaluations, appropriate documentation, and ongoing monitoring—just delivered through a screen instead of an exam room.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Federal Rules: The Foundation

At the federal level, the regulatory picture is clear and favorable for GLP-1 telehealth prescribing. Here’s what you need to know:

The Ryan Haight Act Doesn’t Apply

The Ryan Haight Act—a federal law that typically requires an in-person exam before prescribing controlled substances via telemedicine—does not apply to GLP-1 medications because they aren’t controlled substances. This means there’s no federal barrier to getting Wegovy, Ozempic, or Mounjaro prescribed through telehealth.

COVID-Era Flexibilities Extended

While the pandemic-era telehealth flexibilities for controlled substances (like ADHD medications) have been extended through December 31, 2025, this doesn’t impact GLP-1 prescribing—these medications were always available via telehealth under federal law.

What This Means for You

From a federal perspective, you can legally receive a prescription for these weight loss medications through telehealth without any in-person visit requirement. However, your provider must be licensed in your state, and state-specific rules still apply.

State-Specific Requirements: What You Need to Know

While federal law permits telehealth prescribing of GLP-1 medications, individual states have varying requirements. Some states welcome pure telehealth treatment, while others require at least an initial in-person visit or regular in-person follow-ups.

States with Full Telehealth Access (No In-Person Required)

These states allow you to receive GLP-1 weight loss medications entirely through telehealth, from initial consultation through ongoing care:

• California – Full telehealth permitted with no in-person requirements
• Connecticut – Telehealth allowed, but must include behavioral counseling and diet/exercise planning
• Illinois – No in-person mandate; standard of care applies
• New York – Full telehealth access; must use e-prescribing
• Pennsylvania – No special restrictions on telehealth weight-loss prescribing
• Washington – Pioneering telehealth state with no barriers
• Utah – Telehealth widely used, though initial in-person exam encouraged as best practice

States Requiring Initial In-Person Evaluation

Some states mandate that your first visit happen in person, after which you can continue with telehealth:

• Arkansas – Initial in-person exam required; among the strictest telehealth regulations
• Delaware – First physical exam must be in-person before telehealth prescribing
• Georgia – In-person exam required prior to telehealth prescription
• Mississippi – Must see patient once in-person before telehealth treatment
• New Jersey – Requires comprehensive in-person evaluation including physical exam, labs, and psychological screening
• North Dakota – Hands-on initial evaluation expected
• South Carolina – Initial in-person visit and periodic evaluations required
• Texas – Standard of care typically dictates initial in-person exam
• Virginia – Initial physical exam and lab work required in person, with follow-up within 30 days

States with Special Requirements

Florida stands out with specific conditions for obesity medication prescribing:

• Patients must have a BMI ≥30
• Follow-up visits required at least every 3 months
• No in-person requirement for the visits themselves

Who Can Prescribe Through Telehealth?

Provider qualifications vary significantly by state, which affects your telehealth options:

Physicians (MDs and DOs)

All 50 states allow licensed physicians to prescribe GLP-1 weight loss medications via telehealth (assuming they’re licensed in your state).

Nurse Practitioners (NPs)

As of December 2025, 34 states plus DC allow NPs to practice independently without physician oversight. In these states, you might consult with an NP for your entire weight loss treatment:

Independent Practice States include:

• Alaska, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, Washington, Wisconsin, Wyoming, and Washington DC

Collaborative Practice Required in states like:

• Arkansas, Florida, Georgia, Illinois, Mississippi, Pennsylvania, South Carolina, Texas

In collaborative practice states, NPs must work under a physician agreement, but they can still prescribe these medications through telehealth platforms.

Physician Assistants (PAs)

PAs can prescribe GLP-1 medications in all states, though most require physician supervision or collaboration agreements. The specific requirements mirror those for NPs in most jurisdictions.

Why This Matters: When you use a telehealth service like Klarity Health, you may connect with an MD, DO, NP, or PA depending on your state’s regulations and provider availability. All are qualified to evaluate and treat obesity—what matters is that they’re appropriately licensed and credentialed in your state.

Your Step-by-Step Telehealth Journey

Understanding what to expect can help you prepare for a successful telehealth experience:

1. Initial Consultation and Screening

A legitimate telehealth provider will require:

• Comprehensive medical questionnaire covering your health history, current medications, allergies, and previous weight loss attempts
• Current measurements including height, weight, and BMI calculation (you’ll typically self-report these)
• Medical history review to identify contraindications like personal/family history of medullary thyroid cancer, MEN2 syndrome, active gallbladder disease, history of pancreatitis, or pregnancy
• Live video consultation with a licensed provider to discuss your goals, expectations, and treatment plan

2. Medical Evaluation

During your video visit, your provider will:

• Review your eligibility based on BMI criteria (typically ≥30, or ≥27 with weight-related health conditions)
• Discuss potential side effects like nausea, gastrointestinal upset, and rare but serious risks
• Create a personalized treatment plan that includes lifestyle modifications
• Obtain informed consent documenting that you understand the risks and benefits
• Determine the appropriate starting dose

3. Prescription and Pharmacy

If approved, your provider will:

• Send an electronic prescription to your chosen pharmacy (e-prescribing is required in many states)
• Start with a conservative dose to assess tolerance (typically 4 weeks initially)
• Provide injection training resources or schedule a follow-up to review technique

Important note: As of May 2025, the FDA has banned most compounded versions of semaglutide due to safety concerns. Your prescription should be for the brand-name FDA-approved medication dispensed through a licensed pharmacy.

4. Ongoing Monitoring and Follow-Up

Regular follow-up is essential—and required in some states:

• First follow-up: Typically 2-4 weeks after starting to assess tolerance and side effects
• Ongoing visits: Every 1-3 months to monitor weight loss progress, adjust dosing, and address any concerns
• Lab work: Periodic metabolic panels or A1C tests may be ordered to ensure safety
• Lifestyle coaching: Discussion of diet, exercise, and behavioral strategies alongside medication

Some states mandate specific follow-up schedules. For example, Florida requires visits at least every 3 months, and Virginia mandates a check-in within 30 days of starting treatment.

What Klarity Health Offers

At Klarity Health, we’ve built our telehealth platform with these regulations in mind, making it easy to access weight loss treatment legally and safely:

Transparent Process: Our providers are licensed in your state and follow all state-specific requirements, including any necessary in-person evaluations or follow-up schedules.

Flexible Options: We accept both insurance and cash payment, with transparent pricing so you know your costs upfront.

Available Providers: Our network includes MDs, DOs, and NPs across multiple states, meaning you can typically get an appointment within days, not weeks or months.

Comprehensive Care: Beyond prescriptions, we emphasize the lifestyle changes that make these medications most effective—helping you build sustainable habits for long-term success.

Patient Eligibility: Are You a Candidate?

Not everyone who wants to lose weight qualifies for GLP-1 medications. Here’s what providers look for:

Medical Criteria

You’ll generally need:

• BMI ≥30 (obesity), OR
• BMI ≥27 with at least one weight-related health condition (such as type 2 diabetes, high blood pressure, high cholesterol, or sleep apnea)
• Evidence of previous weight loss attempts through diet and exercise (unless medically inadvisable)
• Commitment to lifestyle changes alongside medication

Disqualifying Conditions

You typically won’t qualify if you have:

• Personal or family history of medullary thyroid carcinoma
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Current pregnancy or plans to become pregnant
• Severe active gallbladder disease
• History of pancreatitis
• Severe gastroparesis or gastrointestinal disorders

Setting Realistic Expectations

These aren’t ‘quick fix’ diet pills. Clinical trials show:

• Average weight loss: 15-20% of body weight over 68 weeks with Wegovy
• Gradual progress: Most significant weight loss occurs over 6-12 months
• Lifestyle matters: Best results occur when combined with reduced calorie intake and increased physical activity
• Long-term commitment: Many patients need to continue medication to maintain weight loss

Reputable telehealth providers will be honest about what these medications can and can’t do, and they’ll screen out patients who aren’t appropriate candidates.

Red Flags: How to Spot Questionable Telehealth Services

Unfortunately, the popularity of GLP-1 medications has attracted some less-than-reputable operators. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions

Red flag: Any service that promises you’ll definitely get a prescription before evaluating you.

What’s legitimate: Real providers reserve the right to decline if you don’t meet medical criteria, even after you’ve paid for a consultation.

Compounded or ‘Generic’ Versions

Red flag: Services offering cheap compounded semaglutide or medications from overseas pharmacies.

What’s legitimate: Since May 2025, FDA-approved medications only—not compounded versions—should be prescribed for weight loss. Legitimate providers prescribe brand-name Wegovy, Ozempic, or Mounjaro/Zepbound filled through U.S.-licensed pharmacies.

Minimal or No Follow-Up

Red flag: Services that send a prescription after a 5-minute questionnaire with no video visit or ongoing monitoring.

What’s legitimate: A thorough initial video consultation (typically 20-30 minutes) and scheduled follow-ups to monitor progress and side effects.

Unclear Provider Credentials

Red flag: You can’t find information about who will prescribe your medication or what state they’re licensed in.

What’s legitimate: Transparent information about provider qualifications, state licensure, and how they meet your state’s specific requirements.

Waiving Your Rights

Red flag: Services asking you to waive liability or accept treatment without informed consent about risks.

What’s legitimate: Clear documentation of potential side effects, appropriate alternatives, and your right to stop treatment at any time.

Bottom line: If something feels off or too good to be true, trust your instincts. Stick with established telehealth companies that prioritize regulatory compliance and patient safety.

Insurance Coverage and Costs

One common question is whether insurance covers telehealth visits and GLP-1 medications for weight loss:

Telehealth Visit Coverage

Most insurance plans now cover telehealth visits at the same rate as in-person appointments, thanks to pandemic-era changes that have largely remained in place. However:

• Your provider must be in-network with your insurance
• Some plans require copays or meet your deductible first
• Verify coverage specifics before booking

Medication Coverage

Insurance coverage for weight loss medications varies significantly:

• Wegovy (FDA-approved for weight loss): Some insurers cover it with prior authorization, but many still exclude weight loss medications from formularies
• Ozempic (used off-label): Usually covered only if you have Type 2 diabetes; off-label weight loss use often denied
• Mounjaro/Zepbound: Similar to Ozempic—diabetes use more likely covered than weight loss

Cash Pay Options

Because insurance coverage is inconsistent, many patients choose cash-pay options:

• Medication costs (without insurance): $900-$1,500 per month for brand-name medications
• Manufacturer savings cards: Novo Nordisk and Eli Lilly offer copay assistance programs that can reduce costs significantly for eligible patients
• Transparent pricing: Klarity Health provides upfront pricing for both visits and medications, accepting insurance when available and offering competitive cash rates

Looking Ahead: The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve, generally in favor of expanded telehealth access:

Federal Developments

• DEA telehealth rules: While current flexibilities for controlled substances expire December 31, 2025, multiple extensions are expected. This doesn’t affect GLP-1 medications, but it signals regulators’ acceptance of telehealth prescribing
• TREATS Act: Bipartisan legislation reintroduced in October 2025 would permanently expand telehealth access for certain medications, reflecting Congressional support for telemedicine
• Medicare coverage: Medicare has extended telehealth coverage for obesity counseling, and there’s ongoing discussion about covering anti-obesity medications

State-Level Changes

Watch for:

• NP practice authority: Several states (including Mississippi and Pennsylvania) have pending legislation to grant NPs full independent practice, which would expand provider availability
• Streamlined requirements: As outcomes data accumulates showing telehealth obesity treatment is safe and effective, more states may relax in-person examination requirements
• Interstate compacts: Growing adoption of interstate licensure compacts makes it easier for providers to treat patients across state lines

What This Means for Patients

Expect telehealth access to weight loss medications to improve over the coming years. More states will likely embrace flexible telehealth models, and provider availability should increase as NP scope of practice expands.

Frequently Asked Questions

Q: Do I need to have an in-person visit before getting a prescription?

A: It depends on your state. About half of states allow pure telehealth treatment with no in-person requirement. States like Arkansas, Georgia, New Jersey, and Texas typically require an initial in-person evaluation. Check the state-specific table in this article for your location.

Q: Can nurse practitioners prescribe these medications?

A: Yes, in all states—though some require physician collaboration. In 34 states plus DC, NPs can practice independently and prescribe GLP-1 medications without physician oversight.

Q: Is it safe to get weight loss medications through telehealth?

A: Yes, when using legitimate telehealth services that follow proper protocols. Reputable providers conduct thorough evaluations, document medical history, obtain informed consent, and schedule regular follow-ups—the same standards as in-person care.

Q: Will my insurance cover telehealth weight loss treatment?

A: Many insurance plans cover telehealth visits, but medication coverage for weight loss varies significantly. Check with your insurer about specific coverage for Wegovy, Ozempic, or Mounjaro. Many patients use manufacturer savings programs or cash-pay options.

Q: How long does it take to get started?

A: With telehealth platforms like Klarity Health, you can typically schedule a video consultation within a few days. If approved, your prescription can be sent to your pharmacy the same day, with medication available within 24-48 hours (depending on pharmacy stock).

Q: What if I move to a different state during treatment?

A: You’ll need to work with a provider licensed in your new state. Some telehealth platforms have multi-state networks that make this transition seamless, but requirements may differ in your new location.

Take the Next Step

If you’re struggling with obesity and haven’t found success with diet and exercise alone, GLP-1 medications might be worth exploring. Telehealth has made access to these treatments more convenient than ever—but make sure you’re working with a legitimate provider who prioritizes your safety.

Ready to explore your options? Klarity Health offers comprehensive telehealth weight loss treatment with licensed providers across multiple states. We accept both insurance and cash pay, with transparent pricing and no hidden fees. Our team can help you understand your state’s specific requirements and determine if you’re a candidate for GLP-1 therapy.

Visit Klarity Health today to schedule a consultation and take the first step toward sustainable weight management with proper medical support.

Sources and Research Currency

Verified as of: December 17, 2025
DEA Rules Status: DEA’s COVID-era telehealth flexibilities remain in effect through December 31, 2025. Non-controlled medications (like GLP-1 agonists) are not subject to the Ryan Haight Act’s in-person rule, so they can be prescribed via telehealth under federal law.

Top Citations:

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – U.S. Drug Enforcement Administration (November 15, 2024) – www.dea.gov

2. The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs – Goodwin Procter LLP (March 27, 2024) – www.goodwinlaw.com

3. COVID-era telehealth prescribing extended – Axios (November 18, 2024) – www.axios.com

4. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing – McDermott Will & Emery (November 18, 2024) – www.mwe.com

5. Know Your State’s Laws Around Semaglutide – Nextech (April 11, 2025) – www.nextech.com

⚠️ Regulatory Note: Federal telehealth rules for controlled substances are temporary (set to expire 12/31/2025) – an additional extension or new rule is expected. State laws are constantly evolving; this information reflects the regulatory status as of December 2025.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid